SCHEMBL6980193

SCHEMBL6980193

Cc1c(CC(=O)O)c[nH]c(=O)c1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
CYP1A2 P05177 1/20 0.38
GRIN2D O15399 4/20 0.34
GRIN3B O60391 4/20 0.34
GRIN1 Q05586 4/20 0.34
GRIN2A Q12879 4/20 0.34
GRIN2B Q13224 4/20 0.34
GRIN2C Q14957 4/20 0.34
GRIN3A Q8TCU5 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
CASP6 P55212 2/20 0.34
TSHR P16473 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
GLA P06280 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
NFKB1 P19838 1/20 0.34
PMP22 Q01453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968540 0.85 PDGFRB (0.40) KDM4EKMT2AHPGDNPSR1SMN1; SMN2
SCHEMBL6975291 0.83 F13A1 (0.36) KDM4EALDH1A1KMT2AHPGDTHRB
SCHEMBL7343469 0.75 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7234126 0.75 CYP1A2 (0.43) KDM4ECYP1A2GRIN2DGRIN3BGRIN1
SCHEMBL722679 0.72 KDM4E (0.55) KDM4ECYP1A2GRIN2DGRIN3BGRIN1
SCHEMBL7005859 0.71 GRIN2D (0.41) KDM4EGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL16317694 0.71 GABRR1 (0.44) KDM4ECYP1A2ALDH1A1MAPTCASP6
SCHEMBL30790196 0.71 GRIN2D (0.42) KDM4ECYP1A2GRIN2DGRIN3BGRIN1
SCHEMBL3649106 0.70 GRIN2D (0.51) KDM4ECYP1A2GRIN2DGRIN3BGRIN1
SCHEMBL4682790 0.70 KDM4E (0.44) KDM4EGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1272487-A1 BICYCLIC HETEROARYL COMPOUNDS AS INHIBITORS OF THE INTERACTION BETWEEN THE INTEGRIN ALPHA4BETA1 RECEPTOR AND VCAM-1 AND/OR FIBRONECTIN AstraZeneca AB (SE) 2003-01-08 EP disclosed
WO-2001053295-A1 BICYCLIC HETEROARYL COMPOUNDS AS INHIBITORS OF THE INTERACTION BETWEEN THE INTEGRIN ALPHA4BETA1 RECEPTOR AND VCAM-1 AND/OR FIBRONECTIN ASTRAZENECA AB (SE) 2001-07-26 WO disclosed